Status:
UNKNOWN
A Trial for the Evaluation of the Treatment and Outcome of Hyperthyroidism With Iodized Salt and Non Iodized Salt
Lead Sponsor:
Xijing Hospital
Conditions:
Hyperthyroidism
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
To clarify the influence of iodine intake in salt on the incidence and treatment of hyperthyroidism patients, so as to provide theoretical basis for accurate formulation of iodine intake in salt, and ...
Eligibility Criteria
Inclusion
- sign informed consent before any research procedure is carried out
- men or women aged 18-65 (equal) at the age of 1.
- had been diagnosed as Graves hyperthyroidism
- patients with hyperthyroidism who had not been treated with drugs or stopped taking medicine for more than 3 months
- reduction to the current dose of hyperthyroidism for more than 2 months
Exclusion
- during the period of pregnancy and lactation, those who plan to be pregnant during the study are not granted medical permission.
- Effective contraceptives
- for the last 1 months or the need for long-term use of amiodarone
- the history of anaphylaxis (such as systemic anaphylaxis, vasoedema, epidermal exfoliation) Etc.)
- consecutive use of beta receptor blockers for the last 2 weeks
- over the past six months, systemic use of corticosteroids (oral or intravenous) is continuous More than 7 days
- there was an obvious liver disease, showing one of the following cases: two consecutive weeks before A. visits.
- It was confirmed that the measurements of AST or ALT were more than 3 times higher than the highest normal value (local data).
- B. bilirubin synthesis and / or excretion disorders (such as hyperbilirubinemia), and other Decompensated liver diseases such as coagulation disorders, hepatic encephalopathy, hypoproteinemia, ascites, and esophagus Bleeding from varicose veins. C. acute viral, active, alcoholic, and alcoholic Other types of hepatitis 7 visits for 4 weeks before the 1 (or the local data), leukopenia (less than 3 \* 10 9 /L) B/ 0 edition of the First Affiliated Hospital of The Fourth Military Medical University The First Affiliated Hospital, the Fourth Military Medical University B/0 Edition Seventh pages / 13 Pages Or neutropenia (less than 1.5 \* 10 9 /L) 8 congestive heart failure at grade III or IV of the New York Heart Association (NYHA) 9 the past 3 months of visit to 1 had a major cardiovascular history, defined as: myocardial infarction Plug and coronary angioplasty or bypass surgery, valvular disease or repair, instability Angina pectoris, transient ischemic attack, or cerebrovascular accident 10 non well controlled atrial fibrillation 11 diagnosis of malignant tumors over the past 5 years 12 history of medullary thyroid carcinoma 13 organ transplantation or AIDS history 14 severe exophthalmos has influenced visual acuity 15 over the last 12 months, there is a history of alcohol abuse or drug abuse
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03444246
Start Date
March 1 2018
End Date
June 1 2019
Last Update
February 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xijing Hospital, Fourth Military Medical university
Xi'an, Shaanxi, China, 710032